For the quarter ending 2026-03-31, SRTAW made $67,384K in revenue. $2,154K in net income. Net profit margin of 3.20%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|
| Revenue | 67,384 | 53,245* | 49,298 | |
| Cost of revenue | 53,267 | 42,963* | 37,684 | |
| Software development | - | - | 453 | |
| Gross profit | 14,117 | 10,282* | - | |
| General and administrative | - | - | 16,301 | |
| Selling, general and administrative | 15,605 | 15,118* | - | |
| Selling and marketing | - | - | 482 | |
| Amortization of intangible assets | 1,486 | 651* | - | |
| Total operating expenses | 17,091 | 15,769* | 54,920 | |
| Operating loss from continuing operations | -2,974 | -5,487* | -5,622 | |
| Interest income, net | 473 | 860* | 1,127 | |
| Change in fair value of warrant liabilities | -1,459 | -4,179* | -33 | |
| Change in fair value of assets and other liabilities | -3,444 | 259* | - | |
| Realized gain from sales of short-term investments | - | 9,612* | -5,195 | |
| Total other non-operating income | 5,376 | 14,392* | -4,035 | |
| Net gain from discontinued operations | -248 | -139,806* | 67,073 | |
| Net income (gain) | 2,154 | -130,901 | 57,416 | |
| Basic EPS | 0.03 | -1.602 | 0.7 | |
| Diluted EPS | 0.03 | -1.602 | 0.7 | |
| Basic Average Shares | 85,322,941 | 81,730,033 | 82,454,657 | |
| Diluted Average Shares | 90,168,853 | 81,730,033 | 82,454,657 | |
Strata Critical Medical, Inc. (SRTAW)
Strata Critical Medical, Inc. (SRTAW)